Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study)

NACompletedINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Diabetes
Interventions
DEVICE

Subjects WITH/WITHOUT Diabetes Use Karajishi Contour BGMS

Untrained subjects WITH and WITHOUT diabetes use Karajishi Contour BGMS (Blood Glucose Monitoring System). Subjects tested capillary fingerstick blood (and study staff tested subject fingerstick blood) using the Karajishi Contour BGMS. All BG results were compared to reference method results obtained with subject capillary plasma. Also, study staff tested subject venous blood and BG results were compared to reference method results obtained from subject venous plasma.

DEVICE

Subjects WITH Diabetes Use Karajishi Contour BGMS

Untrained subjects WITH diabetes use the Karajishi Contour BGMS (Blood Glucose Monitoring System). Subjects tested capillary fingerstick blood (and study staff tested subject fingerstick blood) using the Karajishi Contour BGMS. All BG results were compared to reference method results obtained with subject capillary plasma. Also, study staff tested subject venous blood and BG results were compared to reference method results obtained from subject venous plasma.

Trial Locations (2)

92026

AMCR Institute, Escondido

98057

Rainier Clinical Research Center, Renton

Sponsors
All Listed Sponsors
lead

Ascensia Diabetes Care

INDUSTRY

NCT02150109 - Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study) | Biotech Hunter | Biotech Hunter